{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:50:56Z","timestamp":1793429456168,"version":"4.5.0"},"reference-count":35,"publisher":"Centers for Disease Control MMWR Office","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7209a4","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T07:27:14Z","timestamp":1677742034000},"page":"232-243","source":"Crossref","is-referenced-by-count":119,"title":["Interim Clinical Treatment Considerations for Severe Manifestations of Mpox \u2014 United States, February 2023"],"prefix":"10.15585","volume":"72","author":[{"given":"Agam K.","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Schrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal S.","family":"Minhaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Waltenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shama","family":"Cash-Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yon","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett W.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger K.","family":"Damon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022.","volume":"387","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.15585\/mmwr.mm7123e1","article-title":"Monkeypox outbreak\u2014nine states, May 2022.","volume":"71","author":"Minhaj","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1093\/cid\/ciz286","article-title":"Preemptive tecovirimat use in an active duty service member who presented with acute myeloid leukemia after smallpox vaccination.","volume":"69","author":"Lindholm","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.15585\/mmwr.mm6842a2","article-title":"Novel treatment of a vaccinia virus infection from an occupational needlestick\u2014San Diego, California, 2019.","volume":"68","author":"Whitehouse","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee.","volume":"46","author":"Vora","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R6","first-page":"1204","article-title":"Human vaccinia infection after contact with a raccoon rabies vaccine bait\u2014Pennsylvania, 2009.","volume":"58","author":"CDC","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R7","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/infdis\/jis510","article-title":"Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.","volume":"206","author":"Lederman","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(62)91935-9","article-title":"Antivaccinial gamma-globulin in the control of smallpox.","volume":"1","author":"Hobday","year":"1962","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1542\/peds.26.2.176","article-title":"Studies smallpox and complications of smallpox vaccination.","volume":"26","author":"Kempe","year":"1960","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R10","first-page":"41","article-title":"The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox.","volume":"25","author":"Kempe","year":"1961","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R11","first-page":"325","article-title":"The use of hyperimmune antivaccinia gamma-globulin for the prevention and treatment of smallpox.","volume":"27","author":"Marennikova","year":"1962","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R12","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.15585\/mmwr.mm7144e1","article-title":"Severe monkeypox in hospitalized patients\u2014United States, August 10\u2013October 10, 2022.","volume":"71","author":"Miller","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.15585\/mmwr.mm7144a4","article-title":"Epidemiologic and clinical features of children and adolescents aged \u226418 years with monkeypox\u2014United States, May 17\u2013September 24, 2022.","volume":"71","author":"Hennessee","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15585\/mmwr.mm7201a2","article-title":"Mpox cases among cisgender women and pregnant persons\u2014United States, May 11\u2013November 7, 2022.","volume":"72","author":"Oakley","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/cid\/cir952","article-title":"Eczema vaccinatum.","volume":"54","author":"Reed","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R16","first-page":"1","article-title":"Clinical guidance for smallpox vaccine use in a postevent vaccination program.","volume":"64","author":"Petersen","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.15585\/mmwr.mm7132e4","article-title":"Interim guidance for prevention and treatment of monkeypox in persons with HIV infection\u2014United States, August 2022.","volume":"71","author":"O\u2019Shea","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R18","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/v2112409","article-title":"Development of ST-246\u00ae for treatment of poxvirus infections.","volume":"2","author":"Jordan","year":"2010","journal-title":"Viruses"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R19","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2214921","article-title":"First monkeypox death in the United States.","author":"Alarc\u00f3n","year":"2023","journal-title":"N Engl J Med. In press"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R20","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.","volume":"51","author":"Quenelle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R21","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1128\/AAC.02814-14","article-title":"In vitro efficacy of brincidofovir against variola virus.","volume":"58","author":"Olson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R22","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1586\/14787210.2014.948847","article-title":"Development of CMX001 (brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.","volume":"12","author":"Florescu","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/jac\/dku545","article-title":"ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.","volume":"70","author":"Duraffour","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R24","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1128\/JVI.00605-06","article-title":"Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.","volume":"80","author":"Andrei","year":"2006","journal-title":"J Virol"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/infdis\/jiq103","article-title":"Evaluation of therapeutic interventions for vaccinia virus keratitis.","volume":"203","author":"Altmann","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/archopht.1965.00970040541019","article-title":"Therapy of experimental vaccinal keratitis: effect of idoxuridine and VIG.","volume":"74","author":"Fulginiti","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000221929","article-title":"Growth inhibition of cells in cultures and of vaccinia virus infected HeLa cells by derivatives of trifluorothymidine.","volume":"22","author":"Parkhurst","year":"1976","journal-title":"Chemotherapy"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R28","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1001\/archopht.1976.03910040559015","article-title":"Treatment of vaccinial keratitis with trifluorothymidine.","volume":"94","author":"Hyndiuk","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0002-9394(03)00293-9","article-title":"Ocular complications of smallpox vaccination.","volume":"136","author":"Pepose","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF02307009","article-title":"Corneal epithelial dysplasia after trifluridine use.","volume":"220","author":"Maudgal","year":"1983","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.15585\/mmwr.mm7142e1","article-title":"Ocular monkeypox\u2014United States, July\u2013September 2022.","volume":"71","author":"Cash-Goldwasser","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R32","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.15585\/mmwr.mm7138e1","article-title":"Two cases of monkeypox-associated encephalomyelitis\u2014Colorado and the District of Columbia, July\u2013August 2022.","volume":"71","author":"Pastula","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R33","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.3201\/eid2812.221276","article-title":"Myocarditis attributable to monkeypox virus infection in 2 patients, United States, 2022.","volume":"28","author":"Rodriguez-Nava","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R34","first-page":"1855","article-title":"Experimental variola in monkeys. I. Studies on disease enhancing property of cortisone in smallpox. A preliminary report.","volume":"56","author":"Rao","year":"1968","journal-title":"Indian J Med Res"},{"key":"key-10.15585\/mmwr.mm7209a4-202303020721-R35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1086\/427265","article-title":"Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.","volume":"191","author":"Edghill-Smith","year":"2005","journal-title":"J Infect Dis"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:40:03Z","timestamp":1679877603000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/72\/wr\/mm7209a4.htm?s_cid=mm7209a4_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,3,3]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7209a4","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,3]]},"published":{"date-parts":[[2023,3,3]]}}}